- call +1-201-465-4211
- email sales@mrinsights.biz
Injectable drug delivery is defined as introduction of a drug or drugs in the patient by using a delivery device. Injectables allow the transport of drugs formulated in liquid form, directly in the body. Even though, they may be designed to transport the drug to specific part of the body.
Scope of the Report:
This report studies the Injectable Drug Delivery market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Injectable Drug Delivery market by product type and applications/end industries.
North America is expected to dominate the market in 2018, Asia is expected to grow at the highest CAGR during the forecast period. This growth in this market is attributed to rising incidence of chronic diseases and growing aging population. In addition, high penetration of self-injection technologies in Asian countries such as China, Japan, and India adds to the demand for injectable devices.
The global Injectable Drug Delivery market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Injectable Drug Delivery.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Baxter
Becton, Dickinson
Gerresheimer
Pfizer
Schott
ELI Lilly
Novartis
Terumo
Teva Pharmaceutical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Skin Injection
Circulatory/Musculoskeletal Injection
Organs Injection
Central Nervous System Injection
Market Segment by Applications, can be divided into
Hospitals & Clinics
Home Care Settings
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Injectable Drug Delivery Market Overview
1.1 Product Overview and Scope of Injectable Drug Delivery
1.2 Classification of Injectable Drug Delivery by Types
1.2.1 Global Injectable Drug Delivery Revenue Comparison by Types (2017-2023)
1.2.2 Global Injectable Drug Delivery Revenue Market Share by Types in 2017
1.2.3 Skin Injection
1.2.4 Circulatory/Musculoskeletal Injection
1.2.5 Organs Injection
1.2.6 Central Nervous System Injection
1.3 Global Injectable Drug Delivery Market by Application
1.3.1 Global Injectable Drug Delivery Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals & Clinics
1.3.3 Home Care Settings
1.3.4 Others
1.4 Global Injectable Drug Delivery Market by Regions
1.4.1 Global Injectable Drug Delivery Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Injectable Drug Delivery Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Injectable Drug Delivery Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Injectable Drug Delivery Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Injectable Drug Delivery Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Injectable Drug Delivery Status and Prospect (2013-2023)
1.5 Global Market Size of Injectable Drug Delivery (2013-2023)
2 Manufacturers Profiles
2.1 Baxter
2.1.1 Business Overview
2.1.2 Injectable Drug Delivery Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Baxter Injectable Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.2 Becton, Dickinson
2.2.1 Business Overview
2.2.2 Injectable Drug Delivery Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Becton, Dickinson Injectable Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.3 Gerresheimer
2.3.1 Business Overview
2.3.2 Injectable Drug Delivery Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Gerresheimer Injectable Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Injectable Drug Delivery Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Injectable Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.5 Schott
2.5.1 Business Overview
2.5.2 Injectable Drug Delivery Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Schott Injectable Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.6 ELI Lilly
2.6.1 Business Overview
2.6.2 Injectable Drug Delivery Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 ELI Lilly Injectable Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.7 Novartis
2.7.1 Business Overview
2.7.2 Injectable Drug Delivery Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Novartis Injectable Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.8 Terumo
2.8.1 Business Overview
2.8.2 Injectable Drug Delivery Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Terumo Injectable Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.9 Teva Pharmaceutical
2.9.1 Business Overview
2.9.2 Injectable Drug Delivery Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Teva Pharmaceutical Injectable Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
3 Global Injectable Drug Delivery Market Competition, by Players
3.1 Global Injectable Drug Delivery Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Injectable Drug Delivery Players Market Share
3.2.2 Top 10 Injectable Drug Delivery Players Market Share
3.3 Market Competition Trend
4 Global Injectable Drug Delivery Market Size by Regions
4.1 Global Injectable Drug Delivery Revenue and Market Share by Regions
4.2 North America Injectable Drug Delivery Revenue and Growth Rate (2013-2018)
4.3 Europe Injectable Drug Delivery Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Injectable Drug Delivery Revenue and Growth Rate (2013-2018)
4.5 South America Injectable Drug Delivery Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Injectable Drug Delivery Revenue and Growth Rate (2013-2018)
5 North America Injectable Drug Delivery Revenue by Countries
5.1 North America Injectable Drug Delivery Revenue by Countries (2013-2018)
5.2 USA Injectable Drug Delivery Revenue and Growth Rate (2013-2018)
5.3 Canada Injectable Drug Delivery Revenue and Growth Rate (2013-2018)
5.4 Mexico Injectable Drug Delivery Revenue and Growth Rate (2013-2018)
6 Europe Injectable Drug Delivery Revenue by Countries
6.1 Europe Injectable Drug Delivery Revenue by Countries (2013-2018)
6.2 Germany Injectable Drug Delivery Revenue and Growth Rate (2013-2018)
6.3 UK Injectable Drug Delivery Revenue and Growth Rate (2013-2018)
6.4 France Injectable Drug Delivery Revenue and Growth Rate (2013-2018)
6.5 Russia Injectable Drug Delivery Revenue and Growth Rate (2013-2018)
6.6 Italy Injectable Drug Delivery Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Injectable Drug Delivery Revenue by Countries
7.1 Asia-Pacific Injectable Drug Delivery Revenue by Countries (2013-2018)
7.2 China Injectable Drug Delivery Revenue and Growth Rate (2013-2018)
7.3 Japan Injectable Drug Delivery Revenue and Growth Rate (2013-2018)
7.4 Korea Injectable Drug Delivery Revenue and Growth Rate (2013-2018)
7.5 India Injectable Drug Delivery Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Injectable Drug Delivery Revenue and Growth Rate (2013-2018)
8 South America Injectable Drug Delivery Revenue by Countries
8.1 South America Injectable Drug Delivery Revenue by Countries (2013-2018)
8.2 Brazil Injectable Drug Delivery Revenue and Growth Rate (2013-2018)
8.3 Argentina Injectable Drug Delivery Revenue and Growth Rate (2013-2018)
8.4 Colombia Injectable Drug Delivery Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Injectable Drug Delivery by Countries
9.1 Middle East and Africa Injectable Drug Delivery Revenue by Countries (2013-2018)
9.2 Saudi Arabia Injectable Drug Delivery Revenue and Growth Rate (2013-2018)
9.3 UAE Injectable Drug Delivery Revenue and Growth Rate (2013-2018)
9.4 Egypt Injectable Drug Delivery Revenue and Growth Rate (2013-2018)
9.5 Nigeria Injectable Drug Delivery Revenue and Growth Rate (2013-2018)
9.6 South Africa Injectable Drug Delivery Revenue and Growth Rate (2013-2018)
10 Global Injectable Drug Delivery Market Segment by Type
10.1 Global Injectable Drug Delivery Revenue and Market Share by Type (2013-2018)
10.2 Global Injectable Drug Delivery Market Forecast by Type (2018-2023)
10.3 Skin Injection Revenue Growth Rate (2013-2023)
10.4 Circulatory/Musculoskeletal Injection Revenue Growth Rate (2013-2023)
10.5 Organs Injection Revenue Growth Rate (2013-2023)
10.6 Central Nervous System Injection Revenue Growth Rate (2013-2023)
11 Global Injectable Drug Delivery Market Segment by Application
11.1 Global Injectable Drug Delivery Revenue Market Share by Application (2013-2018)
11.2 Injectable Drug Delivery Market Forecast by Application (2018-2023)
11.3 Hospitals & Clinics Revenue Growth (2013-2018)
11.4 Home Care Settings Revenue Growth (2013-2018)
11.5 Others Revenue Growth (2013-2018)
12 Global Injectable Drug Delivery Market Size Forecast (2018-2023)
12.1 Global Injectable Drug Delivery Market Size Forecast (2018-2023)
12.2 Global Injectable Drug Delivery Market Forecast by Regions (2018-2023)
12.3 North America Injectable Drug Delivery Revenue Market Forecast (2018-2023)
12.4 Europe Injectable Drug Delivery Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Injectable Drug Delivery Revenue Market Forecast (2018-2023)
12.6 South America Injectable Drug Delivery Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Injectable Drug Delivery Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Injectable Drug Delivery Picture
Table Product Specifications of Injectable Drug Delivery
Table Global Injectable Drug Delivery and Revenue (Million USD) Market Spli
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
